Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

A Phase-1 Dose Escalation and Expansion Study of EP0031, a Next-Generation Selective RET Inhibitor (SRI), in Patients with SRI-naïve or Pretreated Advanced RET-altered NSCLC and Other Tumors.

Elena Garralda,Judy S. Wang,Andrew G. Gianoukakis,Matthew H. Taylor,David R. Spigel,Sarina A. Piha-Paul,Daniel Morgensztern,Susanne M. Arnold,Guzman Alonso,Miguel Garcia-Pardo,Javier Garcia-Corbacho,Martin Forster,Matthew G. Krebs,Antoine Italiano,Vivek Subbiah, Sonia Serrano,Geoff Fisher,Sue Brook,Hendrik-Tobias Arkenau,Pilar Garrido

Journal of Clinical Oncology（2024）

Cited 0|Views17

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined